These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 44939)

  • 1. Neisseriaceae, a group of bacteria with dihydrofolate reductases, moderately susceptible to trimethoprim.
    Then RL
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):450-8. PubMed ID: 44939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrofolate reductases in some folate-requiring bacteria with low trimethoprim susceptibility.
    Then RL; Riggenbach H
    Antimicrob Agents Chemother; 1978 Jul; 14(1):112-7. PubMed ID: 686702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydrofolate reductase from Neisseria sp.
    Averett DR; Roth B; Burchall JJ; Baccanari DP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):428-35. PubMed ID: 111611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1979 Jan; 15(1):1-6. PubMed ID: 218496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fragility of the X chromosome and inhibition of dihydrofolate reductase. Comparison of the effects of 2 antibiotics: trimethoprim and pyrimethamine].
    Calva-Mercado MP; Maunoury C; Rethoré MO; Lejeune J
    Ann Genet; 1983; 26(3):147-9. PubMed ID: 6606377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim and brodimoprim resistance of gram-positive and gram-negative bacteria.
    Thomson CJ
    J Chemother; 1993 Dec; 5(6):458-64. PubMed ID: 8195838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Papoulis AT; Queener SF
    J Med Chem; 1998 Mar; 41(6):913-8. PubMed ID: 9526565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).
    Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum.
    Chen GX; Mueller C; Wendlinger M; Zolg JW
    Mol Pharmacol; 1987 Apr; 31(4):430-7. PubMed ID: 3553892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim resistance in enterococci: microbiological and biochemical aspects.
    Hamilton-Miller JM; Stewart S
    Microbios; 1988; 56(226):45-55. PubMed ID: 3237118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388.
    Amyes SG; Smith JT
    Eur J Biochem; 1976 Jan; 61(2):597-603. PubMed ID: 2472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basis of selectivity of antibacterial diaminopyrimidines.
    Baccanari DP; Kuyper LF
    J Chemother; 1993 Dec; 5(6):393-9. PubMed ID: 8195830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
    Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
    Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimicrobial activities of trimethoprim and sulfonamides.
    Burman LG
    Scand J Infect Dis; 1986; 18(1):3-13. PubMed ID: 3515508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dihydrofolate reductases from trimethoprim- and sulfonamide-resistant strains of Neisseria gonorrhoeae.
    Ho RI; Lai PH; Corman L; Ho J; Morse SA
    Sex Transm Dis; 1978; 5(2):43-50. PubMed ID: 10328030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii.
    Gangjee A; Vasudevan A; Queener SF
    J Med Chem; 1997 Sep; 40(19):3032-9. PubMed ID: 9301665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
    Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
    J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
    Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
    Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.